Identification |
Name: | 5,12-Naphthacenedione,10-[(3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-8-[(1S)-1,2-dihydroxyethyl]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-,hydrochloride, (8S,10S)- (9CI) |
Synonyms: | 5,12-Naphthacenedione,10-[(3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-8-(1,2-dihydroxyethyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-,hydrochloride, [8S-[8a,8(R*),10a]]-;13-Dihydroadriamycin hydrochloride; NSC 268238; NSC 268710 |
CAS: | 63950-05-0 |
Molecular Formula: | C27H31 N O11 . Cl H |
Molecular Weight: | 0 |
InChI: | InChI=1/C27H31NO11/c1-10-22(31)13(28)6-17(38-10)39-15-8-27(36,16(30)9-29)7-12-19(15)26(35)21-20(24(12)33)23(32)11-4-3-5-14(37-2)18(11)25(21)34/h3-5,10,13,15-17,22,29-31,33,35-36H,6-9,28H2,1-2H3 |
Molecular Structure: |
|
Properties |
Flash Point: | 455°C |
Boiling Point: | 828.7°C at 760 mmHg |
Density: | 1.61g/cm3 |
Refractive index: | 1.716 |
Specification: | Dark Red Solid usageEng:A metabolite of Doxorubicin as neoplasm inhibitor |
Flash Point: | 455°C |
Usage: | A metabolite of Doxorubicin as neoplasm inhibitor |
Safety Data |
|
|